Research Updates

Back to project

All updates for Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome)

  • November 16, 2026

    2 materials

    A study is examining the surgical risks for patients with hereditary hemorrhagic telangiectasia who have heart infections and unusual bleeding issues. This research may help in understanding how to approach these complex cases (Item 1).

  • November 9, 2026

    5 materials

    A study is exploring a machine learning tool that may help find brain problems in people with HHT using MRI scans (1).

  • November 2, 2026

    2 materials

    A study found that polidocanol sclerotherapy can greatly reduce nosebleeds in people with HHT, and many reported feeling hopeful about this treatment.

  • October 26, 2026

    3 materials

    A new study will explore how HHT affects the quality of life in children and young adults. This is aimed at understanding their daily challenges better. (items: 1)

  • October 19, 2026

    2 materials

    A study found that hereditary hemorrhagic telangiectasia (HHT) is often overlooked in young women with heavy menstrual bleeding, particularly if there’s a family history. This highlights the importance of considering HHT in these cases.

  • October 12, 2026

    13 materials

    A review discusses new therapies aimed at improving outcomes for people with hereditary hemorrhagic telangiectasia (HHT).

  • October 5, 2026

    10 materials

    A patient with Hereditary Hemorrhagic Telangiectasia had a novel gene mutation and suffered a stroke, highlighting a potential complication of the condition.

  • September 28, 2026

    6 materials

    A study compared two lasers for skin treatments in hereditary hemorrhagic telangiectasia, finding one caused less pain and redness.

  • September 24, 2026

    5 materials

    A study found that blood markers in patients with HHT may change during treatment, possibly indicating how well treatments are working (1).

  • September 22, 2026

    16 materials

    A new study plans to evaluate a treatment for severe nosebleeds in HHT patients, considering how individual factors may influence results (Item 3).

  • August 31, 2026

    1 material

    A new study is looking to use liquid biopsies to find genetic changes in brain arteriovenous malformations (bAVMs). This could help with better diagnosis and treatment options for people with HHT.

  • August 28, 2026

    21 materials

    A genetic test confirmed a rare syndrome related to hereditary hemorrhagic telangiectasia, leading to a re-evaluation of family diagnoses (Item 1).

  • August 28, 2026

    1 material

    A new study is being planned to test a treatment called DIAG723 in adults with hereditary hemorrhagic telangiectasia. The study will focus on its safety and early effects.

  • August 28, 2026

    1 material

    The FDA has added a boxed warning for ferric carboxymaltose due to risks of low phosphate levels. This action came after a petition led by Dr. Scott Olitsky from Cure HHT.